Literature DB >> 20854415

Rapid functional definition of extended spectrum β-lactamase activity in bacterial cultures via competitive inhibition of fluorescent substrate cleavage.

Ulysses W Sallum1, Xiang Zheng, Sarika Verma, Tayyaba Hasan.   

Abstract

The functional definition of extended-spectrum β-lactamase (ESBL) activity is a clinical challenge. Here we report a rapid and convenient assay of β-lactamase activity through the competitive inhibition of fluorescent substrate hydrolysis that provides a read-out nearly 40× more rapidly than conventional techniques for functional definition. A panel of β-lactam antibiotics was used for competition against β-lactamase enzyme-activated photosensitizer (β-LEAP) yielding a competitive index (C(i)) in 30 min. Significant differences in the relative C(i) values of the panel of β-lactams were determined in vitro for Bacillus cereus penicillinase. Additionally, the relative C(i) values for whole bacterial cell suspensions of B. cereus 5/β were compared with the relative minimal inhibitory concentration (MIC) values and a correlation coefficient of 0.899 was determined. We further demonstrated the ability of β-LEAP to probe the capacity of ceftazidime to inhibit the enzyme activity of a panel of ESBL-producing Escherichia coli. The bacteria were assayed for susceptibility to ceftazidime and the relative MIC values were compared with the relative C(i) values for ceftazidime yielding a correlation coefficient of 0.984. This work demonstrates for the first time the whole cell assay of the competitive inhibition of β-lactamase enzyme activity and derivation of associated constants.
© 2010 The Authors. Journal Compilation. The American Society of Photobiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854415      PMCID: PMC3118499          DOI: 10.1111/j.1751-1097.2010.00801.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  15 in total

1.  Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA.

Authors:  Xiang Zheng; Ulysses W Sallum; Sarika Verma; Humra Athar; Conor L Evans; Tayyaba Hasan
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

2.  Updated sequence information for TEM beta-lactamase genes.

Authors:  S Goussard; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

3.  Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase.

Authors:  J Péduzzi; M Barthélémy; K Tiwari; D Mattioni; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

4.  Transition state and multisubstrate analog inhibitors.

Authors:  A Radzicka; R Wolfenden
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

Review 5.  Extended-spectrum beta-lactamases in North America, 1987-2006.

Authors:  K Bush
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

6.  Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.

Authors:  Ulysses W Sallum; Thomas T Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

7.  Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae.

Authors:  M H Nicolas; V Jarlier; N Honore; A Philippon; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

8.  Cloning and sequencing of the beta-lactamase I gene of Bacillus cereus 5/B and its expression in Bacillus subtilis.

Authors:  W Wang; P S Mézes; Y Q Yang; R W Blacher; J O Lampen
Journal:  J Bacteriol       Date:  1985-08       Impact factor: 3.490

9.  Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

Authors:  J P Quinn; D Miyashiro; D Sahm; R Flamm; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

10.  Cloning and sequencing of the metallothioprotein beta-lactamase II gene of Bacillus cereus 569/H in Escherichia coli.

Authors:  M Hussain; A Carlino; M J Madonna; J O Lampen
Journal:  J Bacteriol       Date:  1985-10       Impact factor: 3.490

View more
  5 in total

1.  Rapid, low-cost fluorescent assay of β-lactamase-derived antibiotic resistance and related antibiotic susceptibility.

Authors:  S Sibel Erdem; Shazia Khan; Akilan Palanisami; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

2.  Guiding Empiric Treatment for Serious Bacterial Infections via Point of Care [Formula: see text]-Lactamase Characterization.

Authors:  Akilan Palanisami; Shazia Khan; Sultan Sibel Erdem; Tayyaba Hasan
Journal:  IEEE J Transl Eng Health Med       Date:  2016-06-29       Impact factor: 3.316

3.  One-Step Detection and Classification of Bacterial Carbapenemases in 10 Minutes Using Fluorescence Identification of β-Lactamase Activity.

Authors:  Yanfang Feng; Joseph W R Swain; Akilan Palanisami; Shoaib Ashraf; Tayyaba Hasan
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

4.  Rapid optical determination of β-lactamase and antibiotic activity.

Authors:  Shazia Khan; Ulysses W Sallum; Xiang Zheng; Gerard J Nau; Tayyaba Hasan
Journal:  BMC Microbiol       Date:  2014-04-04       Impact factor: 3.605

5.  Novel Rapid Test for Detecting Carbapenemase.

Authors:  Yanfang Feng; Akilan Palanisami; Jerrin Kuriakose; Michael Pigula; Shoaib Ashraf; Tayyaba Hasan
Journal:  Emerg Infect Dis       Date:  2020-04       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.